Zenas BioPharma Eyes US IPO Amid Investor Optimismby Mark Eisenberg 23.08.2024Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO as market hopes for rate cuts and reduced volatility rise.
Investors in Elon Musk’s X Corp Revealedby Mark Eisenberg 23.08.2024Sean “Diddy” Combs among investors in Musk's X Corp after court forces disclosure of stakeholders.
Toll Brothers Reports Strong Q3, Raises Outlookby Mark Eisenberg 23.08.2024Toll Brothers surpasses Q3 expectations with record revenues. Raises full-year outlook amid strong market demand.
Cava’s Q2 Earnings Preview Amid Stock Surgeby Mark Eisenberg 22.08.2024Cava's stock hits record as Q2 results loom. Sales expected to rise, driven by new menu items.
Dow Jones Dips as Fed Comments Awaitedby Mark Eisenberg 22.08.2024Tech stocks slide, Dow Jones lower as investors await Fed comments on interest rate changes at Jackson Hole.
AI Stocks Poised for Growth: AMD and Appleby Lilu Anderson 22.08.2024Explore why Advanced Micro Devices and Apple are top picks for AI investment in 2024's evolving tech landscape.
Revolut Valued at $45B, Challenges Major Banksby Mark Eisenberg 22.08.2024Revolut's $45B valuation surpasses European banks, securing UK banking license to challenge established sectors like mortgages.
India to Seek Public Input on Crypto Regulationby John Darbie 22.08.2024India's government plans to regulate cryptocurrency with public input, aiming for informed and effective rules.
Morgan Stanley Remains Bullish on Japan, Indiaby Mark Eisenberg 22.08.2024Morgan Stanley favors Japan and India stocks, cuts China outlook amid weak growth and persistent deflation concerns.
Nucor’s Executive Compensation Boosts Investor Confidenceby Mark Eisenberg 22.08.2024Nucor's strategic pay plans align with investor goals, enhancing stock value and reducing investment risk.